Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 2
This trial looked at durvalumab for people who have had treatment for non small cell lung cancer (NSCLC) but the cancer has continued to grow.
Recruitment start: 25 February 2014
Recruitment end: 28 December 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
AstraZeneca
NIHR Clinical Research Network: Cancer
Last reviewed: 8 September 2019
CRUK internal database number: 12429
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
